Immune to Cancer: The CRI Blog
-
Have an Autoimmune Disease? You Still May Be Able To Receive Cancer Immunotherapy
A retrospective study finds that immunotherapies are safe and work in many patients with preexisting autoimmune diseases.
-
CRI’s Answer to Cancer
Just after dawn on Saturday, June 25, more than 200 cyclists began to gather in Highland Falls,…
-
Immunotherapy 101? Ask a Scientist
As part of Cancer Immunotherapy Month, Dr. Jeffrey Weber answers pressing questions from patients about cancer immunotherapy.
-
A “White Out” at the NBC TODAY Show Plaza
On Monday, June 20, the Cancer Research Institute visited the NBC TODAY Show Plaza to raise public…
-
ASCO 2016 Update: Tapping into the Potential of Anti-Tumor T Cells
Adoptive T cell therapies provide success against some cancers, hope for several others.
-
Together, we can #WhiteOutCancer!
This year we’re on a mission to White Out Cancer—and we need your help!
-
ASCO 2016 Update: Immunotherapy & Melanoma: The Path to Progress
Improved approaches for treating patients with melanoma.
-
ASCO 2016 Update: Immunotherapy’s Impact in Head & Neck Cancers
Immunotherapy approaches provide improvements for patients with head and neck cancer.
-
What Cancer Patients Should Know: Latest Immunotherapy News from ASCO 2016
Hear from CRI's panel of immunotherapy experts—Drs. Andrew Sikora, Leena Gandhi, and Michel Sadelain—on what patients should…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.